The article linked to above highlights a drug trial for the drug,bapineuzumab, one of the most well known and supposedly promising Alzheimer's drugs currently under development.A week or two ago I also posted this story:
* Groundbreaking Drug Helping Alzheimer's Patients
..which originally was also accompanied by a video (which has since been taken off the net). At the time I couldn't work out what drug the story was referring to as it didn't mention its name, so I promised I would investigate and get back to my readers when I found out. An email from, Dr. Andrea Bozoki, assistant professor of neurology at MSU, a researcher involved in the study, finally reached me yesterday morning, and she confirms that this story was also about a bapineuzumab trial. In the email Dr. Bozoki wrote:
"A similar story but with much better, more complete information can be found in the Lansing State Journal from May 11th, titled A study in hope: experimental drug at MSU may help Alzheimer’s patients. In addition, there is a website to look at: www.icarastudy.com. The drug, bapineuzumab, is a monoclonal antibody directed against amyloid protein, the “bad” protein that is thought to destroy brain cells in Alzheimer’s disease. By giving people the antibody, it is hoped that it will allow their bodies’ immune system to come in and “eat up” (remove) the amyloid from between cells before it can cause more damage.
Our study coordinator is Diane Flatley, who can be reached at 884-2273. You should suggest that individuals look at the website, and if they feel they qualify and want to participate (age 50-88, mild-early moderate AD, no other neurologic diseases, no autoimmune disease and no cancer, living at home with a caregiver who sees them at least 5 days/week), to call us at that number."
Here, also is a recruitment video:
So if you are interested and think you might qualify, I hope the above information helps....
0 comments:
Post a Comment